Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think the time is long past when an Ebola pump would have any chance of working.
I do remember when stockholders expected NNVC to pop every time there was an outbreak of the flu, even though NNVC wasn't expected to have Flucide available as a marketable, approved drug for years.
At the end of September Nanoviricides had about 3 quarters worth of cash left. So they go belly up by July 2019. Anybody buying now is betting that NNVC will get through tox, get an IND approval, and be preparing phase I trials before then, so that the stock price will get pumped up to a dollar or so before NNVC issues a giant block of new shares to stay in business.
Quite a gamble. People buying in the 0.30s might double their money if everything goes smoothly, but it's no sure thing. Anyone who bought at $2 or $3 will probably never be made whole.
The value of the Shelton plant has less to do with Connecticut real estate prices and more to do with the equipment it contains and the capability of Theracour's (or is it AllExcel's) employees to do GMP manufacturing of nanoviricides in it. All of this, of course, assuming that GMP manufacturing can now be done at the Shelton plant, one of those things we can never quite nail down.
No condolences if he had the wisdom to sell at 35 cents.
You're right, I should have said that NNVC can skip partial payments for 6 months. Now, does anyone think anything will happen in that 6 months, like a pre-IND meeting with the FDA?
Theracour has always been a creditor in the fairly trivial sense that each month they send NNVC a bill and NNVC owes them until later in the month when they pay Theracour. But now Theracour is allowing NNVC to skip payments for 6 months, allowing a fairly serious dept to pile up.
This is what I predicted would happen. Theracour is making itself a creditor of NNVC. That way, when NNVC goes bankrupt, Theracour has dibs on NNVC's only asset, the Shelton plant. Stockholders will have no claim on anything whatsoever when NNCV goes tits up.
I do feel bad for Don Pat. If I recall correctly he's pretty much all-in on NNVC. So he has to desperately believe that it's going to work. I have to admit it was hard for me to admit that I had been wrong about NNVC when I sold at $1. Realizing huge losses was tough. But of course now I'm glad I sold when I did.
It looks like the MoneyCentral-NYC pump is in operation.
I still think the 'cides might work. But it doesn't matter because they can't make them in sufficient quantity to test them. NNVC will be flatlined within 8 months whether 'cides work or not.
Realism comes to the bulls' board:
It looks like NNVC will stay at 0.30 until next quarter, when we'll finally be told how much cash they have at hand now.
At least he didn't have to hire an expert writer to write his letter.
It can't stay below 0.30 for long -- this stock is hot! $100 a share any day now!
Who cares what the short interest is?
I agree about that. Of course for years I saw the good doctors giving each other generous salaries and bonuses, while getting nothing done, and the bulls here would say how utterly reasonable their compensation was, and how they deserved more.
Damn, I wish I had paid more attention to Zincfinger.
Dr. Seymour's comments had the effect of precisely undoing the effects of Dr. Taraporewala's letter. We're back at 0.30 even.
Now we know why Eugene left. For exactly the same reasons I bailed out of the stock a year ago.
Indeed. AAPL stock always goes up. Had I followed that rule, and put all the money I had in NNVC into Apple LEAPs instead, I'd be retired by now.
MoneyChannel-NYC all by itself should send this stock roaring to forty cents.
The bulls' board biggest bull:
The rally continues. I am very unlikely to win the strangle contest.
Yup. Another professional pumping operation. That'll get people to buy a stock in a company that is rapidly running out of money.
The letter gives no hint of when the milestones will get completed. There's no reason to believe that anything significant will happen before NNVC runs out of money.
Remember the dark days before the AMEX listing, when NNVC was bottoming out at 0.30, just like now?
Except that was pre-split, so the stock price is now 3.5 times lower now.
Rally day. Only one close below 0.30. The bull market is still on.
Well, some people on the bull's board do understand the current situation (although I'd say that 9 months of cash is a bit optimistic):
Everybody who sold at $1 wishes he had sold at $2 (I know, I'm one of them.)
Everybody who sold at 0.50 wishes he had sold at $1.
Everybody selling at 0.29 wishes he had sold at 0.50.
And soon there will be people kicking themselves for not selling at 0.29 when they had the chance.
I was merely trying to serve as the real Ubernano.
$100 a share! By the end of next month!
I still suspect that Rentec's buggy bot is the only buyer left. I can't imagine a conscious being buying this stock at this point.
Let's wait until we have a couple more closes below 0.30 before we call this "firmly in the .20s".
I believe that Rawnoc said words to the effect that the time would come when people wished they could sell at $2. He was right.
Here's what I've learned from a remarkably unsuccessful career of investing:
1. Never buy a mining stock.
2. Never buy a biotech start up. If you have a strong stomach for risk, do consider shorting them. If you must be in biotech, buy Merck and collect the dividends.
3. When you buy a stock, keep in mind that the person selling you those shares probably knows more than you do.
Remember all the people who thought they were getting this stock at bargain prices when they were snapping up shares at 1.05?
If they were actively trading NNVC there'd be at least some quarters where they'd show no position at all. (This is not the ideal stock for trading because shorting is so difficult, while being short is the position that will most often make money.)
I think the only thing supporting the current price is a buggy program at Rentec.
I'm sure that today was seen as another buying opportunity by Rentec's out of control investment bot.